Comorbidities are common for patients with asthma and chronic obstructive pulmonary disease (COPD) overlap.
Comorbid conditions such as diabetes, cardiovascular disease, and eczema are highly common in individuals with asthma and chronic obstructive pulmonary disease (COPD) syndrome (asthma—COPD overlap), according to a new study published in the Annals of the American Thoracic Society.
Asthma—COPD overlap is when an individual presents symptoms and characteristics of both asthma and COPD. It has been long recognized in clinical practice, but such individuals are often excluded from clinical studies, which makes evaluating and managing this population difficult.
The term “Asthma COPD Overlap Syndrome” was first proposed in 2014 by the Global Initiative for Asthma (GINA) and the Global Initiative for Chronic Obstructive Lung Disease (GOLD) in a joint statement. GINA and GOLD mapped out 11 clinical characteristics that can be used to help identify asthma—COPD overlap, such as age, comorbid conditions, and lung function. Other groups have since issued varying criteria for the diagnosis of asthma–COPD overlap, so the prevalence of asthma–COPD overlap is unclear and varies depending on the criteria.
The study, which was conducted by the Respiratory Effectiveness Group (REG), included 2165 individuals over the age of 40 with at least 2 outpatient primary care visits over a 2-year period. The data was collected from the United Kingdom’s Optimum Patient Care Research Database. Patients were sorted in 3 groups: COPD only, both asthma and COPD, and asthma only. The criteria for asthma—COPD overlap was defined as being at least 40 years old, being a current or former smoker, and post-bronchodilator airflow limitation.
Asthma—COPD overlap’s overall prevalence in the study population was 20%. Of the individuals with asthma–COPD overlap, investigators found that the majority were men with a mean age of 70 years. All the patients were smokers (73% were former smokers, 27% were current smokers) and 66% were overweight or obese. In term of comorbid diseases, 53% had diabetes, 36% had cardiovascular disease, 21% had rhinitis, 30% had hypertension, and 23% had eczema.
Asthma—COPD overlap was most prevalent in the group of patients diagnosed with both asthma and COPD (32%). This is significantly higher than the 20% diagnosed with asthma–COPD overlap in the group just diagnosed with COPD. In the asthma only group, 14% were diagnosed with asthma–COPD overlap.
“Our observations suggest that the source population from which individuals with [asthma—COPD overlap] are identified may contribute to heterogeneity, in estimates of prevalence, demographics, clinical characteristics, and healthy outcomes” the report stated. “Additional studies are needed to confirm this.”
Reference
Krishnan JA, Nibbler A, Chisholm A, et al. Prevalence and characteristics of asthma-COPD overlap in routine primary care practices [published online June 4, 2019]. Ann Am Thorac Soc. doi: 10.1513/AnnalsATS.201809-607OC.
Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk
November 21st 2024Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are inversely associated with chronic obstructive pulmonary disease (COPD) risk, emphasizing the importance of cardiovascular health (CVH) in disease prevention.
Read More
A Pulmonologist on Why You Should Think About Respiratory Health and the Lungs
November 16th 2021On this episode of Managed Care Cast, we speak with MeiLan K. Han, MD, MS, the author of a book released this month called Breathing Lessons: A Doctor’s Guide to Lung Health. Han, a pulmonologist, gives an inside tour of the lungs and how they work, zooms out to examine the drivers of poor respiratory health, and addresses policy changes that are needed to improve lung health.
Listen
Interstitial Lung Abnormalities in Patients With COPD Linked to Cancer, Heart Failure Risks
October 23rd 2024Interstitial lung abnormalities (ILAs) in patients with chronic obstructive pulmonary disease (COPD) are linked to lower lung adenocarcinoma rates but higher rates of other cancers and heart failure.
Read More
Ineligibility, Limitations to PR Uptake in Patients With AECOPD
October 15th 2024Two posters at the CHEST 2024 annual meeting revealed that 18% of eligible patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) participated in post-discharge pulmonary rehabilitation (PR), with ineligibility significantly limiting uptake.
Read More